Pulse wave velocity (PWV) and cardio-ankle vascular index (CAVI) are measurements of arterial stiffness and are widely used as indices of arteriosclerosis. In Japan, brachial-ankle PWV (baPWV) is generally used to measure PWV, and while the reference value for this parameter is specified in Japanese guidelines for the noninvasive vascular function test, the CAVI reference value has not been standardized. We measured CAVI in 4,545 patients with at least one cardiovascular risk factor, and baPWV in 1,737 of these 4,545 patients on the same day as a part of an ongoing nationwide registry. The association between CAVI and baPWV was positive and significant (r = 0.50, p < 0.001). The CAVI corresponding to baPWV 14 m/s derived from the regression line was 8.303 and the CAVI corresponding to baPWV 18 m/s was 9.059. The percentages of patients with low risk (CAVI < 8.303), medium risk (CAVI 8.303–9.058) and high risk (CAVI ≥9.059) were 35.0, 23.0, and 42.0% in 4,545 patients who underwent CAVI, respectively. The percentages of patients with baPWV < 14 m/s, baPWV 14–18 m/s and baPWV ≥18 m/s were 22.9, 47.3, and 29.8% in 1,737 patients who underwent both baPWV and CAVI, respectively. The average baPWV in low-risk patients (CAVI < 8.303, n = 642) was 14.97 ± 2.91 m/s, that in medium-risk patients (CAVI 8.303–9.058, n = 408) was 16.12 ± 2.80 m/s, and that in high-risk patients (CAVI ≥9.059, n = 687) was 18.40 ± 3.51 m/s. CAVI < 8.303 corresponded to a baPWV cutoff of 14 m/s, and CAVI ≥9.059 corresponded to a baPWV cutoff of 18 m/s. The results of this ongoing prospective study are expected to confirm the association between the CAVI reference value and cardiovascular events.

Keywords:
Arteriosclerosis, Arterial stiffness, Pulse wave velocity
1.
Ohkuma T, Ninomiya T, Tomiyama H, Kario K, Hoshide S, Kita Y, Inoguchi T, Maeda Y, Kohara K, Tabara Y, Nakamura M, Ohkubo T, Watada H, Munakata M, Ohishi M, Ito N, Nakamura M, Shoji T, Vlachopoulos C, Yamashina A; Collaborative Group for J-BAVEL (Japan Brachial-Ankle Pulse Wave Velocity Individual Participant Data Meta-Analysis of Prospective Studies): Brachial-ankle pulse wave velocity and the risk prediction of cardiovascular disease: an individual participant data meta-analysis. Hypertension 2017; 69: 1045–1052.
2.
Ninomiya T, Kojima I, Doi Y, Fukuhara M, Hirakawa Y, Hata J, Kitazono T, Kiyohara Y: Brachial-ankle pulse wave velocity predicts the development of cardiovascular disease in a general Japanese population: the Hisayama Study. J Hypertens 2013; 31: 477–483.
3.
Yamashina A, Tomiyama H, Arai T, Hirose K, Koji Y, Hirayama Y, Yamamoto Y, Hori S: Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 2003; 26: 615–622.
4.
Tomiyama H, Matsumoto C, Yamada J, Yoshida M, Odaira M, Shiina K, Nagata M, Yamashina A: Predictors of progression from prehypertension to hypertension. Am J Hypertens 2009; 22: 630–636.
5.
Hayashi K, Yamamoto T, Takahara A, Shirai K: Clinical assessment of arterial stiffness with cardio-ankle vascular index: theory and applications. J Hypertens 2015; 33: 1742–1757.
6.
Gomez-Sanchez L, Garcia-Ortiz L, Patino-Alonso MC, Recio-Rodriguez JI, Rigo F, Martí R, Agudo-Conde C, Rodriguez-Sanchez E, Maderuelo-Fernandez JA, Ramos R, Gomez-Marcos MA; MARK Group: Adiposity measures and arterial stiffness in primary care: the MARK prospective observational study. BMJ Open 2017; 7:e016422.
7.
Kusunose K, Sato M, Yamada H, Saijo Y, Bando M, Hirata Y, Nishio S, Hayashi S, Sata M: Prognostic implications of non-invasive vascular function tests in high-risk atherosclerosis patients. Circ J 2016; 80: 1034–1040.
8.
Saji N, Kimura K, Yagita Y, Kawarai T, Shimizu H, Kita Y: Comparison of arteriosclerotic indicators in patients with ischemic stroke: ankle-brachial index, brachial-ankle pulse wave velocity and cardio-ankle vascular index. Hypertens Res 2015; 38: 323–328.
9.
Chung SL, Yang CC, Chen CC, Hsu YC, Lei MH: Coronary artery calcium score compared with cardio-ankle vascular index in the prediction of cardiovascular events in asymptomatic patients with type 2 diabetes. J Atheroscler Thromb 2015; 22: 1255–1265.
10.
Sato Y, Nagayama D, Saiki A, Watanabe R, Watanabe Y, Imamura H, Yamaguchi T, Ban N, Kawana H, Nagumo A, Ohira M, Endo K, Kurosu T, Tomaru T, Shirai K, Tatsuno I: Cardio-ankle vascular index is independently associated with future cardiovascular events in outpatients with metabolic disorders. J Atheroscler Thromb 2016; 23: 596–605.
11.
Kubota Y, Maebuchi D, Takei M, Inui Y, Sudo Y, Ikegami Y, Fuse J, Sakamoto M, Momiyama Y: Cardio-Ankle Vascular Index is a predictor of cardiovascular events. Artery Res 2011; 5: 91–96.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.